Voloridge Investment Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11M | Sell |
744,654
-436,440
| -37% | -$6.46M | 0.04% | 522 |
|
|
2025
Q1 | $21.2M | Buy |
1,181,094
+173,897
| +17% | +$3.12M | 0.08% | 339 |
|
|
2024
Q4 | $17.5M | Buy |
1,007,197
+253,402
| +34% | +$4.41M | 0.06% | 390 |
|
|
2024
Q3 | $10.5M | Buy |
+753,795
| New | +$10.5M | 0.04% | 570 |
|
|
2023
Q4 | – | Sell |
-17,161
| Closed | -$153K | – | 1488 |
|
|
2023
Q3 | $153K | Buy |
+17,161
| New | +$153K | ﹤0.01% | 1334 |
|
|
2023
Q2 | – | Sell |
-35,617
| Closed | -$801K | – | 1573 |
|
|
2023
Q1 | $801K | Buy |
+35,617
| New | +$801K | ﹤0.01% | 1164 |
|
|
2022
Q2 | – | Sell |
-146,411
| Closed | -$3.77M | – | 1642 |
|
|
2022
Q1 | $3.77M | Buy |
146,411
+76,848
| +110% | +$1.98M | 0.02% | 735 |
|
|
2021
Q4 | $2.16M | Buy |
+69,563
| New | +$2.16M | 0.01% | 1045 |
|
|
2020
Q4 | – | Sell |
-53,807
| Closed | -$993K | – | 1572 |
|
|
2020
Q3 | $993K | Buy |
53,807
+5,687
| +12% | +$105K | 0.01% | 939 |
|
|
2020
Q2 | $982K | Buy |
+48,120
| New | +$982K | 0.01% | 856 |
|
|
2020
Q1 | – | Sell |
-25,178
| Closed | -$358K | – | 1408 |
|
|
2019
Q4 | $358K | Sell |
25,178
-30,104
| -54% | -$428K | 0.01% | 890 |
|
|
2019
Q3 | $641K | Buy |
+55,282
| New | +$641K | 0.01% | 741 |
|
|
2015
Q4 | – | Sell |
-12,209
| Closed | -$247K | – | 307 |
|
|
2015
Q3 | $247K | Buy |
+12,209
| New | +$247K | 0.01% | 259 |
|